PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Looks like we on the move, page-41

  1. 2,137 Posts.
    lightbulb Created with Sketch. 573
    The invention relates a lot to the modification of Modic Endplates by using PPS to treat the condition of Chronic Lower Back Pain, as observed using MRI's. I'm just wondering aloud if they will go ahead and test the indication.

    They may already have, as they are doing MRI's on different joints on patients in trial for Knee OA, they may also be doing MRI's on those in the trial for knee OA, but also present with back pain as well.

    Incredible read. I believe the potential fortunes of Paradigm have been made not only with PPS, but with advancements in MRI technology.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.